BOT meets face-to-face and visits KCDC & LG Chem’s vaccine plant
Members of the IVI Board of Trustees
On Nov. 19, 2018, IVI’s Board of Trustees convened at IVI headquarters in Seoul for their second face-to-face meeting of the year. This was followed by a visit to the Korea Center for Disease Control (KCDC) on Nov. 20 to exchange information on new initiatives, discuss matters of mutual interest, and to explore opportunities to further expand their partnership, as well as a site tour to LG Chem’s vaccine plant in Osong, North Chungcheong Province.
IVI Board Chairman Mr. George Bickerstaff addresses IVI staff.
IVI Board members and senior staff pose with senior KCDC Director, Dr. Jeong Eun-kyeong (center) and other KCDC officials.
IVI Board members take a guided tour of the National Biobank of Korea at KCDC.
Board members and IVI’s senior staff visiting LG Chem’s vaccine plant.
SKYCovione™ is South Korea's first homegrown vaccine to achieve licensure. Photo courtesy of SK bioscience.